Pursuant to President Trump’s Executive Order (EO) on Delivering Most-Favored-Nation (MFN) Prescription Drug Pricing to American Patients, the Department of Health and Human Services (HHS) and the Centers for Medicare and Medicaid Services (CMS) announced that the agencies have identified specific MFN targets pharmaceutical manufacturers are expected to meet to satisfy the requirements of the Executive Order.  Basis for MFN… (Slifer, May 20, 2025) #Drug Pricing, #Prescription Drugs